Key targets of hormone treatment of prostate cancer. Part I: the androgen receptor and steroidogenic pathways.
Pitts
William R
WR
D000726:Androgen Antagonists / Q000627:therapeutic use; D000728:Androgens / Q000378:metabolism*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000378:metabolism*; D013256:Steroids / Q000378:metabolism*
D000726:Androgen Antagonists; D000728:Androgens; D018931:Antineoplastic Agents, Hormonal; D013256:Steroids